Novo Nordisk shares have dropped significantly in ... Considering the high-quality nature of the company and that the stock's earnings are expected to grow by 21.1% this year (according to the ...

However, the company’s strong fundamentals and the untapped nature of the obesity market make us believe that the setback is temporary. Shares of Novo Nordisk have surged more than 175% in the ...